Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Sales & Marketing

Sales & Marketing at other companies

Travel + Leisure logo
Travel + LeisureTNL
$142M+14.5%
GitLab logo
GitLabGTLB
$119.36M+10.9%
PennyMac Financial Services, Inc. logo
PennyMac Financial Services, Inc.PFSI
$21.09M+124%
Federated Hermes logo
Federated HermesFHI
$4.1M-10.4%
Open Text logo
Open TextOTEX
$282.62M+8.7%
IPG Photonics logo
IPG PhotonicsIPGP
$24.53M+0.4%

Segments

By segment

See full
Pharmaceutical Products$3.89M—

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's sales & marketing?
Amphastar Pharmaceuticals (AMPH) reported sales & marketing of $11.93M in Q1 2026.
How has Amphastar Pharmaceuticals's sales & marketing changed year-over-year?
Amphastar Pharmaceuticals's sales & marketing increased by 0.5% year-over-year, from $11.87M to $11.93M.
What is the long-term trend for Amphastar Pharmaceuticals's sales & marketing?
Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's sales & marketing has grown at a 25.9% compound annual growth rate (CAGR), from $17.49M to $43.89M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.